Efficacy And Safety Of Low Dose Tofacitinib As Induction Therapy In Moderate To Severe Ulcerative Colitis: A Pilot Study
Objective: The Inflammatory cascade has been the root cause of ulcerative colitis's pathogenesis, and its treatment would centre upon reducing its intensity. Tofacitinib, an orally administered micromolecule, blocks the Janus kinase (JAK) signal transducer pathway, thereby reducing mucosal inf...
Saved in:
Main Authors: | Sadia Ahmed, Muhammad Umar, Muhammad Kamran, Misbah Noureen, Iqra Ashraf, Javeria Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Rawalpindi Medical University
2024-12-01
|
Series: | Journal of Rawalpindi Medical College |
Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/2421 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of Collagenous Colitis into Severe and Extensive Ulcerative Colitis
by: Hugh J Freeman, et al.
Published: (2007-01-01) -
Colonic cytokines for severe ulcerative colitis
by: Ye. A. Konovich, et al.
Published: (2016-08-01) -
Severe and Extensive Enteritis following Colectomy for Ulcerative Colitis
by: Greg Rosenfeld, et al.
Published: (2012-01-01) -
Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study
by: Christopher Ma, et al.
Published: (2016-01-01) -
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)